CD34 and neoplasm: Several quality measures were compared including median number of CD34+ cells/kg collected, median number of CFU-GM/kg, median hospital stay, incidence of infections, time to engraftment of granulocytes and platelets, and evidence of tumor mobilization by peripheral smear.